There is no better-known disease for which there is seemingly no cure than cancer. It touches each of our lives, directly or indirectly. In fact, more than 30,000 Kentuckians will discover they have cancer this year. Sadly, just over 10,000 will die from the disease. However, thanks to advancements in early cancer detection, there is…
To Keep Kentucky’s Independent Pharmacies Alive, Congress Must Rein in Bad Actors
By Taylor Williams From my University of Kentucky College of Pharmacy graduation, to beginning a new job at the Kentucky Pharmacists Association and visiting our federal officials on Capitol Hill, the summer of 2023 has been filled with many exciting first-time opportunities for a young healthcare professional from Hazard. Growing up, I spent many years…
Sen. McConnell: Help Ease Burden on Kentucky Hospitals
By Susan Murphy, PhD Kentucky’s health care providers have been put to the test throughout the COVID-19 pandemic. Despite facing massive losses due to suspending everything but the most essential services while preparing for a surge of COVID-19 cases, providers continued to serve our most vulnerable citizens. Now, however, overly stringent federal loan repayment terms…
Pfizer Outlines Five-Point Plan to Battle COVID-19
Pharmaceutical manufacturer Pfizer issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19. Dr. Albert Bourla, Chairman and CEO, made the following statement: “In this troubling time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic. Many companies, including…
New Law to Address Concerns in 340b Program
By John Hayden More than 25 years ago, Congress enacted the 340B drug discount program with bipartisan support. The 340B program gives hospitals and clinics that largely serve uninsured and low-income patients steep discounts for their medications. However, recent evidence demonstrates that some bad actors are taking advantage of the 340B program for their own…
A Balancing Act: Pending Legislation Seeks to Improve Prescription Drug Access While Curbing Abuse
By Susan Bizzell and Nicholas Gonzales Executive Summary On July 29, 2014, legislation designed to both combat prescription drug abuse and ensure patient access to prescription drugs advanced by voice vote in the House of Representatives. This legislation, bolstered by bipartisan sponsorship from Reps. Marsha Blackburn (R-Tenn.), Judy Chu (D-Calif.), Tom Marino (R-Pa.) and Peter Welch…
- 1
- 2